Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Repurchased Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Fulcrum Therapeutics (FULC) Change in Intangibles (2019)

Fulcrum Therapeutics (FULC) has 1 years of Change in Intangibles data on record, last reported at $91000.0 in Q1 2019.

On a quarterly basis, Change in Intangibles changed N/A to $91000.0 in Q1 2019 year-over-year; TTM through Dec 2019 was $91000.0, a N/A change, with the full-year FY2019 number at $91000.0, changed N/A from a year prior.
Change in Intangibles reached $91000.0 in Q1 2019 per FULC's latest filing.
Over the last five years, Change in Intangibles for FULC hit a ceiling of $91000.0 in Q1 2019 and a floor of $91000.0 in Q1 2019.